Unternehmen
NETHERLANDS CENTER FOR THE CLINICAL ADVANCEMENT OF STEM CELL & GENE THERAPIES BV
NETHERLANDS CENTER FOR THE CLINICAL ADVANCEMENT OF STEM CELL & GENE THERAPIES BV – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application
Hematopoietic stem cells (HSC) are an elusive cell type, whose presence can only be inferred retrospectively, from the outcome of… Beitrag ansehen →
Projekt
→
Clinical portfolio strategy for regenerative muscle stem cell therapies
MyoPax is a women founded company with locations in Germany and in Denmark. Myopax uses a proprietary, patented, first-in-class s… Beitrag ansehen →
Projekt
→
A simple blood test to choose the best treatment for each patient with depression.
Major depressive disorder affects around 300M people globally and is the second leading cause of disability, with up to 14 years… Beitrag ansehen →
Projekt
→
NOn-VIral gene modified STEM cell therapy
Despite the increasing awareness that cell and gene-therapy approaches have tremendous biomedical potential, their broad clinical… Beitrag ansehen →
Projekt
→
Dissecting the molecular regulation of hematopoietic stem cell emergence using pluripotent stem cells to improve ex vivo therapies
Although hematopoietic stem cell (HSCs) transplantation is routinely used to treat blood disorders, immune incompatibility and do… Beitrag ansehen →
Projekt
→
Next-generation models and genetic therapies for rare neuromuscular diseases
Muscular dystrophies are severe genetic disorders characterised by muscle wasting, impaired mobility and premature death, which t… Beitrag ansehen →
Passend zu diesem Beitrag